Galmed Pharmaceuticals (GLMD) Return on Equity (2016 - 2020)

Galmed Pharmaceuticals' Return on Equity history runs 5 years deep, the most recent figure standing at 0.0% for Q4 2020.

• In Q4 2020, Return on Equity changed 0.0% year-over-year to 0.0%; the TTM figure through Dec 2020 stood at 0.0% (changed 0.0% YoY), while the FY2024 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Equity was 0.0% for Q4 2020 at Galmed Pharmaceuticals, down from 0.0% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.02% in Q3 2017 to a low of 0.0% in Q3 2018.
• Historically, Return on Equity has averaged 0.01% across 5 years, with a median of 0.0% in 2020.
• The sharpest annual moves came in 2017 and 2018: Return on Equity gained 1 bps in 2017, then fell 2 bps in 2018.
• A 5-year view of Return on Equity shows it stood at 0.01% in 2016, then fell by 12 bps to 0.01% in 2017, then tumbled by 90 bps to 0.0% in 2018, then jumped by 115 bps to 0.0% in 2019, then slumped by 41 bps to 0.0% in 2020.
• The last three Return on Equity figures came in at 0.0% (Q4 2020), 0.0% (Q3 2020), and 0.0% (Q2 2020), per Business Quant data.